Neusoft Medical’s Cardiology CAD Software Gets SFDA Nod
This article was originally published in PharmAsia News
Executive Summary
Neusoft Medical System has received China's State FDA approval for its Cardiology Computer-Aided Diagnosis (CAD) 2.0 system. This is the second SFDA certification for the company's CAD software, the first being MammoCAD. Clinical testing of CardioCAD2.0 shows that its effectiveness and safety standards are equal to world-class products, providing doctors an analysis platform of heart vessel CT images. CardioCAD's successful development by a Chinese firm represents a significant milestone for the specialized field; it not only breaks the monopoly MNCs hold in domestic and international markets, but also brings new choices to the health care industry. (Click here for more - Chinese Language)